LPAR3 and ovarian cancer: Direct targeting of LPAR3 by miR-15b has been shown to repress cell proliferation and drive the senescence and apoptosis of ovarian cancer cells through the PI3K/Akt pathway [64], suggesting the potential mRNA treatment against LPAR3.